The DOI matches its Crossref record; 31 of the 33 references it cites were found in a registry or an index.
Meta-analyses with industry involvement are massively published and report no caveats for antidepressants
Abstract
Objectives To identify the impact of industry involvement in the publication and interpretation of meta-analyses of antidepressant trials in depression.Study design and setting Using MEDLINE, we identified all meta-analyses evaluating antidepressants for depression published in January 2007-March 2014. We extracted data pertaining to author affiliations, conflicts of interest, and whether the conclusion of the abstract included negative statements on whether the antidepressant(s) were effective or safe.Results We identified 185 eligible meta-analyses. Fifty-four meta-analyses (29%) had authors who were employees of the assessed drug manufacturer, and 147 (79%) had some industry link (sponsorship or authors who were industry employees and/or had conflicts of interest). Only 58 meta-analyses (31%) had negative statements in the concluding statement of the abstract. Meta-analyses including an author who were employees of the manufacturer of the assessed drug were 22-fold less likely to have negative statements about the drug than other meta-analyses [1/54 (2%) vs. 57/131 (44%); P < 0.001].Conclusion There is a massive production of meta-analyses of antidepressants for depression authored by or linked to the industry, and they almost never report any caveats about antidepressants in their abstracts. Our findings add a note of caution for meta-analyses with ties to the manufacturers of the assessed products.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Generally, all the previous reviews show that antidepressants seem to have statistically significant effects on depressive symptoms”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [30]
In the citing paper
“All these previous reviews show that antidepressants have statistically significant effects on depressive symptoms.”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [30]
In the citing paper
“Ebrahim et al 30 identified 185 eligible meta-analyses assessing the effects of different antidepressants, and in the meta-analyses including an author who was an employee of the manufacturer of the assessed drug, these were 22-fold less likely to have negative statements about the drug than other meta-analyses.”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [30]
Citations
Cites
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Finding What Works in Health Care: Standards for Systematic Reviews
Eden, J., Levit, L. A., Berg, A. O., & Morton, S. C. (2013) · Cited by 943
Epidemiology and reporting characteristics of systematic reviews.
Moher, D., Tetzlaff, J., Tricco, A. C., Sampson, M., & Altman, D. G. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040078 · Cited by 891
Jørgensen, A. W., Hilden, J., & Gøtzsche, P. C. (2006) · BMJ · doi:10.1136/bmj.38973.444699.0b · Cited by 439
Overlapping meta-analyses on the same topic: survey of published studies
Siontis, K. C., Hernandez‐Boussard, T., & Ioannidis, J. P. A. (2013) · BMJ · doi:10.1136/bmj.f4501 · Cited by 249
Self-citationYank, V., Rennie, D., & Bero, L. A. (2007) · BMJ · doi:10.1136/bmj.39376.447211.be · Cited by 235
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Sismondo, S., Busuioc, O. A., & Bero, L. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033 · Cited by 166
Stamatakis, E., Weiler, R., & Ioannidis, J. P. A. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12074 · Cited by 115
Self-citationContent area experts as authors: helpful or harmful for systematic reviews and meta-analyses?
Gøtzsche, P. C., & Ioannidis, J. P. A. (2012) · BMJ · doi:10.1136/bmj.e7031 · Cited by 106
Self-citationIndustry sponsorship and selection of comparators in randomized clinical trials
Lathyris, D., Patsopoulos, N. A., Salanti, G., & Ioannidis, J. P. A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02240.x · Cited by 102
Self-citationFinancial Conflicts of Interest and Conclusions About Neuraminidase Inhibitors for Influenza
Dunn, A. G., Arachi, D., Hudgins, J. D., Tsafnat, G., Coiera, E. W., & Bourgeois, F. T. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0933 · Cited by 83
Jørgensen, A. W., Maric, K. L., Tendal, B., Faurschou, A., & Gøtzsche, P. C. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-60 · Cited by 80
From Disclosure to Transparency
Chimonas, S. C., Frosch, Z. A., & Rothman, D. J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.341 · Cited by 79
A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder
Fleurence, R., Williamson, R., Jing, Y., Kim, E., Tran, Q.-V., Pikalov, A., & Thase, M. E. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4089 · Cited by 65
Industry funding and the reporting quality of large long-term weight loss trials
Thomas, O., Thabane, L., Douketis, J. D., Chu, R., Westfall, A. O., & Allison, D. B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.137 · Cited by 64
Relationship between drug company funding and outcomes of clinical psychiatric research
KELLY, R. E., Cohen, L. J., Semple, R. J., Bialer, P. A., Lau, A., BODENHEIMER, A., NEUSTADTER, E., Barenboim, A., & GALYNKER, I. I. (2006) · Psychological Medicine · doi:10.1017/s0033291706008567 · Cited by 64
Profile of Adverse Events with Duloxetine Treatment
Brunton, S., Wang, F., Edwards, S. B., Crucitti, A. S., Ossanna, M. J., Walker, D. J., & Robinson, M. J. (2010) · Drug Safety · doi:10.2165/11319200-000000000-00000 · Cited by 61
Khan, N. A., Lombeida, J., Singh, M., Spencer, H. J., & Torralba, K. D. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34393 · Cited by 56
Shahid, S., Bessarab, D. C., Howat, P. A., & Thompson, S. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-60 · Cited by 55
Fugh‐Berman, A., McDonald, C. P., Bell, A. M., Bethards, E. C., & Scialli, A. R. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000425 · Cited by 52
Treatment Success in Cancer: Industry Compared to Publicly Sponsored Randomized Controlled Trials
Djulbegović, B., Kumar, A., Miladinović, B., Reljic, T., Galeb, S., Mhaskar, A., Mhaskar, R. S., Hozo, I., Tu, D., Stanton, H. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058711 · Cited by 44
Hartog, C. S., Skupin, H., Natanson, C., Sun, J., & Reinhart, K. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2614-0 · Cited by 43
Robinson, D. S., Gilmor, M. L., Gilmor, M. L., PhD, Yang, Y., PhD, Moonsammy, G., PhD, Azzaro, A. J., PhD, et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4106 · Cited by 31
Tatsioni, A., Siontis, G. C. M., & Ioannidis, J. P. A. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1360-7 · Cited by 27
Self-citationMost meta-analyses of drug interventions have narrow scopes and many focus on specific agents
Haidich, A., Pilalas, D., Contopoulos‐Ioannidis, D. G., & Ioannidis, J. P. A. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.10.014 · Cited by 25
Self-citationShould journals stop publishing research funded by the drug industry?
Smith, R. W., Gøtzsche, P. C., & Groves, T. (2014) · BMJ · doi:10.1136/bmj.g171 · Cited by 24
Sponsorship-Related Outcome Selection Bias in Published Economic Studies of Triptans
Peura, P. K., Martikainen, J. A., Purmonen, T. T., & Turunen, J. H. O. (2011) · Medical Decision Making · doi:10.1177/0272989x11403834 · Cited by 19
Guay, D. R. P. (2012) · The Consultant Pharmacist · doi:10.4140/tcp.n.2012.857 · Cited by 12
Industry-Funded Versus Publicly Funded Trials: Are the Standards the Same?
Reynolds, T. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1590 · Cited by 6
Flagged first, then by citations
2 of the 33 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses
IOANNIDIS, J. P. A. (2016) · The Milbank Quarterly · doi:10.1111/1468-0009.12210 · Cited by 1,483
Self-citationThe neurocognitive profile of attention-deficit/hyperactivity disorder: a review of meta-analyses
Pievsky, M. A., & McGrath, R. E. (2018) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx055 · Cited by 401
Evidence-based medicine has been hijacked: a report to David Sackett
Ioannidis, J. P. A. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.02.012 · Cited by 305
Self-citationJohnson, B. T., & Hennessy, E. A. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2019.05.035 · Cited by 238
Ioannidis, J. P. A. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-097621 · Cited by 189
Self-citation
Metadata
- Authors
- Ebrahim, S., Bance, S., Athale, A., Malachowski, C., & Ioannidis, J. P. A.
- Affiliations
- Hospital for Sick Children (CA)
- University of Toronto (CA)
- Stanford Medicine (US)
- Corresponding author
- Ioannidis, John P.A.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 70
- Pages
- 155-163
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W1953543234
- Cited by
- 107
- References
- 33
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 11 · 2019: 19 · 2018: 18 · 2017: 18 · 2016: 11
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- antidepressants, depression, meta-analysis, industry funding, conflicts of interest, pharmaceutical industry, author affiliation, publication bias, drug safety, drug effectiveness
- MeSH terms
- Antidepressive Agents, Depression, Drug Industry, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Conflict of Interest
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
